☰

Kin-Hoe Chow, Ph.D. - Publications

Affiliations: 
2011 Oncological Sciences University of Utah, Salt Lake City, UT 
Area:
Cell Biology, Biochemistry, Molecular Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, ... ... Chow KH, et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature. 580: 517-523. PMID 32322066 DOI: 10.1038/S41586-020-2209-9  0.306
2020 Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu B, Bohrson CL, Cortes-Ciriano I, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ramkissoon SH, Dubois F, Bellamy C, Currimjee N, ... ... Chow K, et al. Abstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas Cancer Research. 80: 5705-5705. DOI: 10.1158/1538-7445.Am2020-5705  0.329
2019 Day M, Maclay T, Cyr A, Hasham MG, Chow K, Keniston E, Mills K. Targeting Homologous Recombination in Lymphoid Malignancies: Evaluation of Four Small Molecule Inhibitors of RAD51 Blood. 134: 2080-2080. DOI: 10.1182/Blood-2019-131747  0.363
2018 Wilson JJ, Chow KH, Labrie NJ, Branca JA, Sproule TJ, Perkins BRA, Wolf EE, Costa M, Stafford G, Rosales C, Mills KD, Roopenian DC, Hasham MG. Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition. Cancer Biology & Therapy. 1-14. PMID 30183475 DOI: 10.1080/15384047.2018.1507666  0.349
2018 Hasham M, Chow K, Maclay T, Cyr A, Patrick D, Day M, Mills KD. Abstract 347: Targeting the AICDA/RAD51 axis: A novel gain-of-function synthetic lethal therapy for the treatment of AICDA-expressing cancers Cancer Research. 78: 347-347. DOI: 10.1158/1538-7445.Am2018-347  0.379
2018 Hasham MG, Chow K, Wilson J, LaBrie N, Perkins B, Branca J, Sproule T, Roopenian D. Abstract A115: Targeting glycolysis and RAD51-dependent repair in B-lymphoid cancers Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A115  0.36
2016 Chow K, Park HJ, George J, Gallup AD, Neilson E, Yun K. Abstract 2522: S100A4 is a critical regulator of stemness and the mesenchymal phenotype in GBMs Cancer Research. 76: 2522-2522. DOI: 10.1158/1538-7445.Am2016-2522  0.317
2014 Chow KH, Elgort S, Dasso M, Powers MA, Ullman KS. The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function. Molecular Biology of the Cell. 25: 160-8. PMID 24196834 DOI: 10.1091/Mbc.E13-05-0256  0.556
2012 Chow KH, Elgort S, Dasso M, Ullman KS. Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2. Nucleus (Austin, Tex.). 3: 349-58. PMID 22688647 DOI: 10.4161/Nucl.20822  0.545
2012 Chow KH, Factor RE, Ullman KS. The nuclear envelope environment and its cancer connections. Nature Reviews. Cancer. 12: 196-209. PMID 22337151 DOI: 10.1038/Nrc3219  0.562
Show low-probability matches.